KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Chemed (CHE) Consolidated Net Income (2016 - 2025)

Historic Consolidated Net Income for Chemed (CHE) over the last 17 years, with Q3 2025 value amounting to $64.2 million.

  • Chemed's Consolidated Net Income fell 1522.78% to $64.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $278.8 million, marking a year-over-year decrease of 759.84%. This contributed to the annual value of $302.0 million for FY2024, which is 1082.17% up from last year.
  • As of Q3 2025, Chemed's Consolidated Net Income stood at $64.2 million, which was down 1522.78% from $52.5 million recorded in Q2 2025.
  • Chemed's 5-year Consolidated Net Income high stood at $90.3 million for Q4 2024, and its period low was $52.5 million during Q2 2025.
  • In the last 5 years, Chemed's Consolidated Net Income had a median value of $65.4 million in 2021 and averaged $67.4 million.
  • As far as peak fluctuations go, Chemed's Consolidated Net Income crashed by 3439.68% in 2021, and later skyrocketed by 4495.22% in 2023.
  • Chemed's Consolidated Net Income (Quarter) stood at $74.6 million in 2021, then dropped by 16.75% to $62.1 million in 2022, then surged by 44.95% to $90.1 million in 2023, then grew by 0.3% to $90.3 million in 2024, then decreased by 28.88% to $64.2 million in 2025.
  • Its Consolidated Net Income was $64.2 million in Q3 2025, compared to $52.5 million in Q2 2025 and $71.8 million in Q1 2025.